Cytopathology Manager of Operations Indiana University Health
BIOGRAPHY
SEP 17, 2024 9:00 AM PDT
A Paradigm Shift to Extended HPV Genotyping - Getting to the COR of the matter
Speaker
Event Date & Time
Date: September 17, 2024
Time: 9:00 AM (PST), 12:00 PM (EST), 6:00 PM (CET)
Abstract
Discover the latest innovations in cervical cancer prevention and molecular diagnostics. This event will showcase cutting-edge advancements in integrated molecular automation and innovative assay design, with a specific focus on transforming screening practices through HPV self-collection in healthcare settings and extended genotyping designed to enhance risk assessment.
Learning Objectives:
- Insightful Presentations: Learn from an industry leader about the impact of integrated molecular automation on laboratory efficiency and throughput.
- Innovative Assay Design: Explore the capabilities of the BD Onclarity™ HPV Assay, the first FDA-approved test for extended genotyping, designed to provide comprehensive risk assessment.
- Addressing Barriers: Understand how expanded HPV self-collection is improving screening access and patient engagement, reshaping cervical cancer screening paradigms.
Secure Your Spot:
Don't miss this opportunity to be at the forefront of transformative technologies driving the future of cervical cancer screening. Register now to join us as we shape the next era of healthcare together!
Webinars will be available for unlimited on-demand viewing after live event.
You May Also Like
DEC 05, 2025 | 1:00 PM
C.E. CREDITS
Explore the evolution, methods, and limitations of mixing studies in detecting factor deficiencies and lupus anticoagulants in coagulation testing....
DEC 09, 2025 | 10:00 AM
Antibody-drug conjugates (ADCs) are transforming oncology by combining the precision of monoclonal antibodies with the potency of cytotoxic drugs. Yet, developing effective ADCs requires ove...
DEC 09, 2025 | 10:00 AM
Ensuring quality and compliance is at the core of every successful clinical laboratory. This webinar brings together CAP expert Daniel and Christie, QA leader from Burning Rock, to explore t...
DEC 10, 2025 | 2:00 PM
Colorectal cancer (CRC) is the second-leading cause of cancer-related deaths in Europe and the U.S.—yet when detected early, the 5-year survival rate jumps to 91% . While colonoscopy r...
DEC 10, 2025 | 8:00 AM
Mass spectrometry (MS)-based proteomic biomarker discovery pipeline commonly begins with large-scale profiling techniques detecting thousands of candidate biomarkers. Efficiently triaging th...
DEC 10, 2025 | 9:00 AM
BACKGROUND . Myelodysplastic syndromes (MDS) are a heterogeneous group of myeloid neoplasms with variable clinical outcomes and an increased risk of progression to Acute Myeloid Leukemia (AM...
Loading Comments...